Skip to content

Clinical trials

Phase 3 Digestive System Diseases trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 3 Country / region: Austria Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20161
20191
20201
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.2
89bio, Inc.1
Abbott1
Celgene1
Sumitomo Pharma America, Inc.1
Vir Biotechnology, Inc.1
Zealand Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases8
Liver Diseases5
Adenocarcinoma3
Digestive System Neoplasms3
Neoplasms3
Neoplasms by Site3
Bile Duct Diseases2
Biliary Tract Diseases2
Cholestasis2
Endocrine Gland Neoplasms2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.